Myrexis Inc

SciGene Corporation, located in Santa Clara, CA, specializes in innovative solutions for fluorescence in situ hybridization (FISH) and karyotyping applications. Their product lineup includes advanced systems such as the Scorpion Robot, MicroFISH System, and various FISH reagents designed to enhance laboratory efficiency and accuracy. In addition to their core products, SciGene offers essential tools like the Hybex Incubator and Little Dipper Processor, along with a range of supportive materials including wash buffers and stabilizing agents. The company is committed to providing comprehensive technical support and resources to ensure optimal use of their products in scientific research. Generated from the website

SomaGenics develops and provides novel RNA-based gene inhibitors for functional genomics and therapeutics. The company specializes in tools and technologies for drug discovery. It researches inflammatory and autoimmune disorders, HIV and hepatitis C. SomaGenics' primary platform technology is a gene-targeting approach called the RNA Lasso. RNA Lassos have potential applications in drug target discovery, therapeutics, research, and diagnostics. The RNA Lasso platform technology provides a significant advance in addressing diagnostics for research, agricultural, veterinary, food, and medical testing, as well as drug development and discovery. In addition to therapeutic development, SomaGenics has several technology applications available for licensing with partners. The company is based in Santa Cruz, Calif.

Aragen Bioscience is a prominent research and development partner for the global biotech industry, focusing on accelerating innovation and product development from initial concepts to clinical applications. With a dedicated team and advanced technology platforms, the company operates two campuses in the San Francisco Bay Area, specializing in biologics solutions, preclinical efficacy testing, and a diverse range of therapeutic areas. Committed to fostering partnerships with biotechnology companies, health organizations, and academic institutions, Aragen supports a multitude of projects including recombinant protein production, biosimilar development, and animal health improvements. Their expertise and comprehensive services ensure quality outcomes and facilitate the transformation of scientific research into viable therapeutic solutions. Generated from the website